Results 261 to 270 of about 8,218,767 (336)

Disaggregation Regression and Multi-Model Evaluation for Predicting Dengue Risk in Africa

Poongavanan J, Lucas TC, Mwanyika G, Kraemer MU, Lourenço J, Dunaiski M, de Oliveira T, Tegally H, This is an initiative of the CLIMADE Consortium.   +8 more
europepmc   +1 more source

In Vitro Dynamic Model Evaluation of Meropenem Alone and in Combination with Avibactam Against Carbapenemase-Producing Klebsiella pneumoniae. [PDF]

Pharmaceuticals (Basel)
Strukova EN, Portnoy YA, Golikova MV, Zinner SH.   +3 more
europepmc   +1 more source

An investment model of a future CO2 free district heating system - Evaluation of the district heating system in Gothenburg in the year 2030

, 2015
Oskar Lundahl, Alexander Kärkkäinen
openalex   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Prediction and model evaluation for space-time data. [PDF]

J Appl Stat
Watson GL, Reid CE, Jerrett M, Telesca D.   +3 more
europepmc   +1 more source

An evaluation of a model health plan for the medically needy in Multnomah County, Oregon.

, 1982
JD Bentkover, Frank G. Feeley, Rebecca Hancock, J Johnston, Donna Lawrence, H.A. Tilson   +5 more
openalex   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Practical Methodology in Kinetic Modeling for Complex Reactions: Weighted Error Manipulation to Allow Effective Model Evaluation in a Borderline S_N Reaction. [PDF]

ACS Omega
Orito Y.
europepmc   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

Physically consistent mesoscale model evaluation in complex terrain

Simonet G, Lehner M, Rotach M.
europepmc   +1 more source